MYnd Analytics Inc (MYND) Director John Pappajohn Acquires 100,000 Shares

MYnd Analytics Inc (NASDAQ:MYND) Director John Pappajohn purchased 100,000 shares of the business’s stock in a transaction that occurred on Thursday, March 14th. The shares were purchased at an average price of $1.68 per share, for a total transaction of $168,000.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

NASDAQ:MYND traded down $0.10 during mid-day trading on Thursday, hitting $1.60. 415,022 shares of the stock traded hands, compared to its average volume of 263,903. MYnd Analytics Inc has a 52 week low of $0.62 and a 52 week high of $4.08. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 0.54.

MYnd Analytics (NASDAQ:MYND) last issued its quarterly earnings results on Tuesday, December 11th. The company reported ($0.20) EPS for the quarter. The firm had revenue of $0.34 million for the quarter. MYnd Analytics had a negative net margin of 589.07% and a negative return on equity of 430.80%.



Separately, Maxim Group reiterated a “buy” rating and set a $5.00 price target on shares of MYnd Analytics in a report on Thursday, December 13th.

COPYRIGHT VIOLATION NOTICE: “MYnd Analytics Inc (MYND) Director John Pappajohn Acquires 100,000 Shares” was first posted by Dakota Financial News and is the sole property of of Dakota Financial News. If you are reading this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be viewed at https://dakotafinancialnews.com/2019/03/15/mynd-analytics-inc-mynd-director-john-pappajohn-acquires-100000-shares.html.

MYnd Analytics Company Profile

MYnd Analytics, Inc operates as a predictive analytics company that has developed a decision support tool to help physicians reduce trial and error treatment in mental health and provide more personalized care to patients. It provides objective clinical decision support to mental healthcare providers for the personalized treatment of behavioural disorders, includes depression, anxiety, bipolar disorder, post-traumatic stress disorder, and other non-psychotic disorders.

See Also: What is a bull market?

Receive News & Ratings for MYnd Analytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MYnd Analytics and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply